Liver Transplantation for Alcoholic and Nonalcoholic Fatty Liver Disease: Pretransplant Selection and Posttransplant Management

Gastroenterology

Volumn 150, Issue 8, 2016, Pages 1849-1862

  Shadab Siddiqui, M ^a   Charlton, Michael ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b INTERMOUNTAIN MEDICAL CENTER   (United States)

Author keywords

Acute Alcoholic Hepatitis; Nonalcoholic steatohepatitis; Obesity

Indexed keywords

ALCOHOL USE DISORDER; ALCOHOLIC FATTY LIVER; ARTICLE; GRAFT FAILURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT; LIVER TRANSPLANTATION; NONALCOHOLIC FATTY LIVER; PATIENT SELECTION; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PREVENTION AND CONTROL; PRIORITY JOURNAL; RECURRENT DISEASE; SURVIVAL TIME; TREATMENT OUTCOME; COMPLICATION; FATTY LIVER, ALCOHOLIC; LIVER CIRRHOSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; UNITED STATES;

FATTY LIVER, ALCOHOLIC; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; NON-ALCOHOLIC FATTY LIVER DISEASE; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RECURRENCE; TREATMENT OUTCOME; UNITED STATES;

EID: 84971268713     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.02.077     Document Type: Article

References (152)

1. M.R. Charlton, J.M. Burns, R.A. Pedersen, and et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the united states Gastroenterology 141 2011 1249 1253
2. R.S. O'Shea, S. Dasarathy, and A.J. McCullough Practice Guideline Committee of the American Association for the Study of Liver Diseases, Practice Parameters Committee of the American College of Gastroenterology. Alcoholic liver disease Hepatology 51 2010 307 328
3. R.N. MacSween, and A.D. Burt Histologic spectrum of alcoholic liver disease Semin Liver Dis 6 1986 221 232
4. S. Bellentani, G. Saccoccio, G. Costa, and et al. Drinking habits as cofactors of risk for alcohol induced liver damage. the dionysos study group Gut 41 1997 845 850
5. G. Corrao, V. Bagnardi, A. Zambon, and et al. Meta-analysis of alcohol intake in relation to risk of liver cirrhosis Alcohol Alcohol 33 1998 381 392
6. N. Chalasani, Z. Younossi, J.E. Lavine, and et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association Hepatology 2012 55
7. E.M. Brunt, C.G. Janney, A.M. Di Bisceglie, and et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am J Gastroenterol 94 1999 2467 2474
8. S. Chitturi, S. Abeygunasekera, G.C. Farrell, and et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome Hepatology 35 2002 373 379
9. G. Pagano, G. Pacini, G. Musso, and et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association Hepatology 35 2002 367 372
10. M. Hamaguchi, T. Kojima, N. Takeda, and et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease Ann Intern Med 143 2005 722 728
11. G. Marchesini, E. Bugianesi, G. Forlani, and et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome Hepatology 37 2003 917 923
12. G.E. Vaillant A 60-year follow-up of alcoholic men Addiction 98 2003 1043 1051
13. C.S. Lieber, D.P. Jones, and L.M. Decarli Effects of prolonged ethanol intake: production of fatty liver despite adequate diets J Clin Invest 44 1965 1009 1021
14. T.I. Sorensen, M. Orholm, K.D. Bentsen, and et al. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis Lancet 2 1984 241 244
15. M.R. Teli, C.P. Day, A.D. Burt, and et al. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver Lancet 346 1995 987 990
16. M. Ramstedt Per capita alcohol consumption and liver cirrhosis mortality in 14 European countries Addiction 96 Suppl 1 2001 S19 S33
17. G. Askgaard, M. Gronbaek, M.S. Kjaer, and et al. Alcohol drinking pattern and risk of alcoholic liver cirrhosis: a prospective cohort study J Hepatol 62 2015 1061 1067
18. U. Becker, M. Gronbaek, D. Johansen, and et al. Lower risk for alcohol-induced cirrhosis in wine drinkers Hepatology 35 2002 868 875
19. E. Barrio, S. Tome, I. Rodriguez, and et al. Liver disease in heavy drinkers with and without alcohol withdrawal syndrome Alcohol Clin Exp Res 28 2004 131 136
20. N. Sato, K.O. Lindros, E. Baraona, and et al. Sex difference in alcohol-related organ injury Alcohol Clin Exp Res 25 Suppl ISBRA 2001 40S 45S
21. S.H. Stewart Racial and ethnic differences in alcohol-associated aspartate aminotransferase and gamma-glutamyltransferase elevation Arch Intern Med 162 2002 2236 2239
22. F.S. Stinson, B.F. Grant, and M.C. Dufour The critical dimension of ethnicity in liver cirrhosis mortality statistics Alcohol Clin Exp Res 25 2001 1181 1187
23. S.N. Wickramasinghe, B. Corridan, J. Izaguirre, and et al. Ethnic differences in the biological consequences of alcohol abuse: a comparison between South Asian and European males Alcohol Alcohol 30 1995 675 680
24. A. Monto, K. Patel, A. Bostrom, and et al. Risks of a range of alcohol intake on hepatitis C-related fibrosis Hepatology 39 2004 826 834
25. J. Rehm, A.V. Samokhvalov, and K.D. Shield Global burden of alcoholic liver diseases J Hepatol 59 2013 160 168
26. P. McMaster Transplantation for alcoholic liver disease in an era of organ shortage Lancet 355 2000 424 425
27. J. Neuberger, D. Adams, P. MacMaster, and et al. Assessing priorities for allocation of donor liver grafts: survey of public and clinicians BMJ 317 1998 172 175
28. P. Burra, M. Senzolo, R. Adam, and et al. Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry) Am J Transplant 10 2010 138 148
29. P. Burra, M. Senzolo, R. Adam, and et al. Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry) Am J Transplant 10 2010 138 148
30. P. Mathurin, F. Beuzin, A. Louvet, and et al. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features Aliment Pharmacol Ther 25 2007 1047 1054
31. P. Mathurin, C. Moreno, D. Samuel, and et al. Early liver transplantation for severe alcoholic hepatitis N Engl J Med 365 2011 1790 1800
32. J.D. Browning, L.S. Szczepaniak, R. Dobbins, and et al. Prevalence of hepatic steatosis in an urban population in the united states: Impact of ethnicity Hepatology 40 2004 1387 1395
33. J.P. Boyle, A.A. Honeycutt, K.M. Narayan, and et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S Diabetes Care 24 2001 1936 1940
34. L.A. Adams, J.F. Lymp, J. St Sauver, and et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study Gastroenterology 129 2005 113 121
35. M. Ekstedt, L.E. Franzen, U.L. Mathiesen, and et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes Hepatology 44 2006 865 873
36. C. Söderberg, P. Stål, J. Askling, and et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up Hepatology 51 2010 595 602
37. N. Rafiq, C. Bai, Y. Fang, and et al. Long-term follow-up of patients with nonalcoholic fatty liver Clin Gastroenterol Hepatol 7 2009 234 238
38. Z.M. Younossi, M. Stepanova, N. Rafiq, and et al. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality Hepatology 53 2011 1874 1882
39. M. Ekstedt, H. Hagstrom, P. Nasr, and et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up Hepatology 61 2015 1547 1554
40. P. Angulo, D.E. Kleiner, S. Dam-Larsen, and et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease Gastroenterology 149 2015 389 397.e10
41. S.A. Harrison, S. Torgerson, and P.H. Hayashi The natural history of nonalcoholic fatty liver disease: a clinical histopathological study Am J Gastroenterol 98 2003 2042 2047
42. L.A. Adams, S. Sanderson, K.D. Lindor, and et al. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies J Hepatol 42 2005 132 138
43. C.D. Evans, K.A. Oien, R.N. MacSween, and et al. Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury? J Clin Pathol 55 2002 689 692
44. P. Sorrentino, L. Terracciano, S. D'Angelo, and et al. Predicting fibrosis worsening in obese patients with NASH through parenchymal fibronectin, HOMA-IR, and hypertension Am J Gastroenterol 105 2010 336 344
45. D.M. Torres, and S.A. Harrison Is it time to write a prescription for coffee? Coffee and liver disease Gastroenterology 144 2013 670 672
46. G.S. Masterton, and P.C. Hayes Coffee and the liver: a potential treatment for liver disease? Eur J Gastroenterol Hepatol 22 2010 1277 1283
47. I.S. Cadden, N. Partovi, and E.M. Yoshida Review article: possible beneficial effects of coffee on liver disease and function Aliment Pharmacol Ther 26 2007 1 8
48. P. Angulo Nonalcoholic fatty liver disease and liver transplantation Liver Transpl 12 2006 523 534
49. M. Charlton Nonalcoholic fatty liver disease: a review of current understanding and future impact Clin Gastroenterol Hepatol 2 2004 1048 1058
50. R.J. Wong, M. Aguilar, R. Cheung, and et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States Gastroenterology 148 2015 547 555
51. R.J. Wong, R. Cheung, and A. Ahmed Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S Hepatology 59 2014 2188 2195
52. M.R. Lucey, K.A. Brown, G.T. Everson, and et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases Transplantation 66 1998 956 962
53. J.F. Alexander, M.W. Lischner, and J.T. Galambos Natural history of alcoholic hepatitis. II. The long-term prognosis Am J Gastroenterol 56 1971 515 525
54. W. Dunn, L.H. Jamil, L.S. Brown, and et al. MELD accurately predicts mortality in patients with alcoholic hepatitis Hepatology 41 2005 353 358
55. A. Louvet, S. Naveau, M. Abdelnour, and et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids Hepatology 45 2007 1348 1354
56. M.A. Dew, A.F. DiMartini, J. Steel, and et al. Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs Liver Transpl 14 2008 159 172
57. A. De Gottardi, L. Spahr, P. Gelez, and et al. A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years Arch Intern Med 167 2007 1183 1188
58. R. Pfitzmann, J. Schwenzer, N. Rayes, and et al. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease Liver Transpl 13 2007 197 205
59. D.L. Haller, M.C. Acosta, D. Lewis, and et al. Hair analysis versus conventional methods of drug testing in substance abusers seeking organ transplantation Am J Transplant 10 2010 1305 1311
60. V.R. Julapalli, J.R. Kramer, and H.B. El-Serag American Association for the Study of Liver Diseases. Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large veterans affairs center Liver Transpl 11 2005 1370 1378
61. K. Webb, L. Shepherd, E. Day, and et al. Transplantation for alcoholic liver disease: report of a consensus meeting Liver Transpl 12 2006 301 305
62. A.K. Singal, H. Bashar, B.S. Anand, and et al. Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: exploratory analysis from the UNOS database Hepatology 55 2012 1398 1405
63. G. Targher, L. Bertolini, R. Padovani, and et al. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease Diabetes Care 29 2006 1325 1330
64. A.J. Dare, L.D. Plank, A.R. Phillips, and et al. Additive effect of pretransplant obesity, diabetes, and cardiovascular risk factors on outcomes after liver transplantation Liver Transpl 20 2014 281 290
65. E.B. Keeffe, C. Gettys, and C.O. Esquivel Liver transplantation in patients with severe obesity Transplantation 57 1994 309 311
66. S. Nair, D.B. Cohen, M.P. Cohen, and et al. Postoperative morbidity, mortality, costs, and long-term survival in severely obese patients undergoing orthotopic liver transplantation Am J Gastroenterol 96 2001 842 845
67. R.G. Sawyer, S.J. Pelletier, and T.L. Pruett Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation Clin Transplant 13 1999 126 130
68. A.R. Hakeem, A.J. Cockbain, S.S. Raza, and et al. Increased morbidity in overweight and obese liver transplant recipients: a single-center experience of 1325 patients from the united kingdom Liver Transpl 19 2013 551 562
69. S. Nair, S. Verma, and P.J. Thuluvath Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the united states Hepatology 35 2002 105 109
70. K.F. Murray, and R.L. Carithers Jr. AASLD. AASLD practice guidelines: evaluation of the patient for liver transplantation Hepatology 41 2005 1407 1432
71. A. Singhal, G.C. Wilson, K. Wima, and et al. Impact of recipient morbid obesity on outcomes after liver transplantation Transpl Int 28 2015 148 155
72. S.E. Perez-Protto, C. Quintini, L.F. Reynolds, and et al. Comparable graft and patient survival in lean and obese liver transplant recipients Liver Transpl 19 2013 907 915
73. J.K. Heimbach, K.D. Watt, J.J. Poterucha, and et al. Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease Am J Transplant 13 2013 363 368
74. P.R. John, and P.J. Thuluvath Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus Liver Transpl 8 2002 708 713
75. R.J. Wong, R. Cheung, R.B. Perumpail, and et al. Diabetes mellitus, and not obesity, is associated with lower survival following liver transplantation Dig Dis Sci 60 2015 1036 1044
76. Z.M. Younossi, M. Stepanova, S. Saab, and et al. The impact of type 2 diabetes and obesity on the long-term outcomes of more than 85 000 liver transplant recipients in the US Aliment Pharmacol Ther 40 2014 686 694
77. A. Wallia, N.D. Parikh, M.E. Molitch, and et al. Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection Transplantation 89 2010 222 226
78. Q. Ling, X. Xu, Q. Wei, and et al. Impact of preexisting diabetes mellitus on outcome after liver transplantation in patients with hepatitis B virus-related liver disease Dig Dis Sci 56 2011 889 893
79. H. Ahmadieh, and S.T. Azar Liver disease and diabetes: association, pathophysiology, and management Diabetes Res Clin Pract 104 2014 53 62
80. W.D. Carey, J.A. Dumot, R.R. Pimentel, and et al. The prevalence of coronary artery disease in liver transplant candidates over age 50 Transplantation 59 1995 859 864
81. J.S. Plotkin, V.L. Scott, A. Pinna, and et al. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation Liver Transpl Surg 2 1996 426 430
82. G. Targher, C.P. Day, and E. Bonora Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease N Engl J Med 363 2010 1341 1350
83. K.L. Lentine, S.P. Costa, M.R. Weir, and et al. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology foundation: endorsed by the American Society of Transplant Surgeons, American Society of Transplantation, and National Kidney Foundation Circulation 126 2012 617 663
84. K. Williams, J.F. Lewis, G. Davis, and et al. Dobutamine stress echocardiography in patients undergoing liver transplantation evaluation Transplantation 69 2000 2354 2356
85. S.M. Bradley, L.A. Soine, J.H. Caldwell, and et al. Screening stress myocardial perfusion imaging and eligibility for liver transplantation Am J Cardiol 105 2010 1010 1013
86. S.D. Tiukinhoy-Laing, J.S. Rossi, M. Bayram, and et al. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation Am J Cardiol 98 2006 178 181
87. A. Ali, H.L. Bhardwaj, D.M. Heuman, and et al. Coronary events in patients undergoing orthotopic liver transplantation: perioperative evaluation and management Clin Transplant 27 2013 E207 E215
88. J.G. O'Leary, C. Landaverde, L. Jennings, and et al. Patients with NASH and cryptogenic cirrhosis are less likely than those with hepatitis C to receive liver transplants Clin Gastroenterol Hepatol 9 2011 700 704.e1
89. A. DiMartini, N. Day, M.A. Dew, and et al. Alcohol use following liver transplantation: a comparison of follow-up methods Psychosomatics 42 2001 55 62
90. A. DiMartini, M.A. Dew, N. Day, and et al. Trajectories of alcohol consumption following liver transplantation Am J Transplant 10 2010 2305 2312
91. J. Dumortier, S. Dharancy, A. Cannesson, and et al. Recurrent alcoholic cirrhosis in severe alcoholic relapse after liver transplantation: a frequent and serious complication Am J Gastroenterol 110 2015 1160 1166
92. A. Cuadrado, E. Fabrega, F. Casafont, and et al. Alcohol recidivism impairs long-term patient survival after orthotopic liver transplantation for alcoholic liver disease Liver Transpl 11 2005 420 426
93. S. Faure, A. Herrero, B. Jung, and et al. Excessive alcohol consumption after liver transplantation impacts on long-term survival, whatever the primary indication J Hepatol 57 2012 306 312
94. D.M. Bravata, I. Olkin, A.E. Barnato, and et al. Employment and alcohol use after liver transplantation for alcoholic and nonalcoholic liver disease: a systematic review Liver Transpl 7 2001 191 203
95. H. Tang, R. Boulton, B. Gunson, and et al. Patterns of alcohol consumption after liver transplantation Gut 43 1998 140 145
96. M. Kelly, J. Chick, R. Gribble, and et al. Predictors of relapse to harmful alcohol after orthotopic liver transplantation Alcohol Alcohol 41 2006 278 283
97. Z. Karim, P. Intaraprasong, C.H. Scudamore, and et al. Predictors of relapse to significant alcohol drinking after liver transplantation Can J Gastroenterol 24 2010 245 250
98. H. Egawa, K. Nishimura, S. Teramukai, and et al. Risk factors for alcohol relapse after liver transplantation for alcoholic cirrhosis in Japan Liver Transpl 20 2014 298 310
99. H.S. Conjeevaram, J. Hart, T.W. Lissoos, and et al. Rapidly progressive liver injury and fatal alcoholic hepatitis occurring after liver transplantation in alcoholic patients Transplantation 67 1999 1562 1568
100. J.P. Rice, J. Eickhoff, R. Agni, and et al. Abusive drinking after liver transplantation is associated with allograft loss and advanced allograft fibrosis Liver Transpl 19 2013 1377 1386
101. I.A. Rowe, K. Webb, B.K. Gunson, and et al. The impact of disease recurrence on graft survival following liver transplantation: a single centre experience Transpl Int 21 2008 459 465
102. C.S. Ahn, S. Hwang, K.H. Kim, and et al. Long-term outcome of living donor liver transplantation for patients with alcoholic liver disease Transplant Proc 46 2014 761 766
103. X. Wang, J. Li, D.R. Riaz, and et al. Outcomes of liver transplantation for nonalcoholic steatohepatitis: a systematic review and meta-analysis Clin Gastroenterol Hepatol 12 2014 394 402.e1
104. M.S. Siddiqui, and R.K. Sterling Posttransplant metabolic syndrome Int J Hepatol 2012 2012 891516
105. M.J. Contos, W. Cales, R.K. Sterling, and et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis Liver Transpl 7 2001 363 373
106. K. Yalamanchili, S. Saadeh, G.B. Klintmalm, and et al. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease Liver Transpl 16 2010 431 439
107. P. Dureja, J. Mellinger, R. Agni, and et al. NAFLD recurrence in liver transplant recipients Transplantation 91 2011 684 689
108. K. Yamaguchi, L. Yang, S. McCall, and et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis Hepatology 45 2007 1366 1374
109. J. Dumortier, E. Giostra, S. Belbouab, and et al. Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil" Am J Gastroenterol 105 2010 613 620
110. S. Seo, K. Maganti, M. Khehra, and et al. De novo nonalcoholic fatty liver disease after liver transplantation Liver Transpl 13 2007 844 847
111. L.G. Lim, C.L. Cheng, A. Wee, and et al. Prevalence and clinical associations of posttransplant fatty liver disease Liver Int 27 2007 76 80
112. M. Vallin, O. Guillaud, O. Boillot, and et al. Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis Liver Transpl 20 2014 1064 1071
113. H. Kim, K. Lee, K.W. Lee, and et al. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation Clin Transplant 28 2014 521 529
114. A. Singal, K. Watt, J. Heimbach, and et al. Recurrence of metabolic syndrome and nonalcoholic steatohepatitis after liver transplantation Hepatology 53 Suppl 2012
115. Z.T. Liu, T.C. Chen, X.X. Lu, and et al. PNPLA3 I148M variant affects non-alcoholic fatty liver disease in liver transplant recipients World J Gastroenterol 21 2015 10054 10056
116. D.C. Rockey, S.H. Caldwell, Z.D. Goodman, and et al. Liver biopsy Hepatology 49 2009 1017 1044
117. V. Ratziu, F. Charlotte, A. Heurtier, and et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease Gastroenterology 128 2005 1898 1906
118. A.L. Fracanzani, L. Valenti, E. Bugianesi, and et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes Hepatology 48 2008 792 798
119. V.W. Wong, J. Vergniol, G.L. Wong, and et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease Hepatology 51 2010 454 462
120. L. Castera Noninvasive evaluation of nonalcoholic fatty liver disease Semin Liver Dis 35 2015 291 303
121. L. Castera, J. Foucher, P.H. Bernard, and et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations Hepatology 51 2010 828 835
122. G. Georgiou, K. Webb, K. Griggs, and et al. First report of a psychosocial intervention for patients with alcohol-related liver disease undergoing liver transplantation Liver Transpl 9 2003 772 775
123. M.R. Lucey, D.E. Schaubel, M.K. Guidinger, and et al. Effect of alcoholic liver disease and hepatitis C infection on waiting list and posttransplant mortality and transplant survival benefit Hepatology 50 2009 400 406
124. A.K. Singal, B.S. Hmoud, P. Guturu, and et al. Outcome after liver transplantation for cirrhosis due to alcohol and hepatitis C: comparison to alcoholic cirrhosis and hepatitis C cirrhosis J Clin Gastroenterol 47 2013 727 733
125. K.D. Watt, R.A. Pedersen, W.K. Kremers, and et al. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study Am J Transplant 10 2010 1420 1427
126. K.D. Watt, and M.R. Charlton Metabolic syndrome and liver transplantation: a review and guide to management J Hepatol 53 2010 199 206
127. K.D. Watt, R.A. Pedersen, W.K. Kremers, and et al. Long-term probability of and mortality from de novo malignancy after liver transplantation Gastroenterology 137 2009 2010 2017
128. C. Jimenez-Romero, A. Manrique Municio, E. Marques Medina, and et al. Incidence of de novo nonmelanoma skin tumors after liver transplantation for alcoholic and nonalcoholic liver diseases Transplant Proc 38 2006 2505 2507
129. E. Chak, and S. Saab Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review Liver Int 30 2010 1247 1258
130. H.K. Seitz, and F. Stickel Molecular mechanisms of alcohol-mediated carcinogenesis Nat Rev Cancer 7 2007 599 612
131. S.L. Ehlers, J.R. Rodrigue, M.R. Widows, and et al. Tobacco use before and after liver transplantation: a single center survey and implications for clinical practice and research Liver Transpl 10 2004 412 417
132. A. Finkenstedt, I.W. Graziadei, W. Oberaigner, and et al. Extensive surveillance promotes early diagnosis and improved survival of de novo malignancies in liver transplant recipients Am J Transplant 9 2009 2355 2361
133. M. Shah, A. Shankar, I. Gee, and et al. A retrospective 15-year review: survival advantage after switching to sirolimus in hepatitis C virus infected liver graft recipients Aliment Pharmacol Ther 41 2015 379 392
134. C. Jimenez-Romero, A. Manrique, E. Marques, and et al. Switching to sirolimus monotherapy for de novo tumors after liver transplantation. A preliminary experience Hepatogastroenterology 58 2011 115 121
135. N.J. van der Zijl, C.C. Moors, G.H. Goossens, and et al. Does interference with the renin-angiotensin system protect against diabetes? Evidence and mechanisms Diabetes Obes Metab 14 2012 586 595
136. R. Belfort, S.A. Harrison, K. Brown, and et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis N Engl J Med 355 2006 2297 2307
137. A.J. Sanyal, N. Chalasani, K.V. Kowdley, and et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis N Engl J Med 362 2010 1675 1685
138. C.O. Zein, L.M. Yerian, P. Gogate, and et al. Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial Hepatology 54 2011 1610 1619
139. E. Vilar-Gomez, Y. Martinez-Perez, L. Calzadilla-Bertot, and et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis Gastroenterology 149 2015 367 378.e5 quiz e14-e15
140. G. Lassailly, R. Caiazzo, D. Buob, and et al. Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients Gastroenterology 149 2015 379 388 quiz e15-e16
141. J.M. Butte, N. Devaud, N.P. Jarufe, and et al. Sleeve gastrectomy as treatment for severe obesity after orthotopic liver transplantation Obes Surg 17 2007 1517 1519
142. D.S. Tichansky, and A.K. Madan Laparoscopic roux-en-Y gastric bypass is safe and feasible after orthotopic liver transplantation Obes Surg 15 2005 1481 1486
143. A. Duchini, and M.E. Brunson Roux-en-Y gastric bypass for recurrent nonalcoholic steatohepatitis in liver transplant recipients with morbid obesity Transplantation 72 2001 156 159
144. A.R. Al-Nowaylati, B.J. Al-Haddad, R.B. Dorman, and et al. Gastric bypass after liver transplantation Liver Transpl 19 2013 1324 1329
145. R. Chhatrala, M.B. Siddiqui, R.T. Stravitz, and et al. Evolution of the serum atherogenic risk in liver transplant recipients; role of lipoproteins, metabolic and inflammatory markers Liver Transpl 21 2015 623 630
146. M.O. Idowu, R. Chhatrala, M.B. Siddiqui, and et al. De novo hepatic steatosis drives atherogenic risk in liver transplant recipients Liver Transpl 21 2015 1395 1402
147. D.L. Segev, S.M. Sozio, E.J. Shin, and et al. Steroid avoidance in liver transplantation: meta-analysis and meta-regression of randomized trials Liver Transpl 14 2008 512 525
148. S.A. Farkas, A.A. Schnitzbauer, G. Kirchner, and et al. Calcineurin inhibitor minimization protocols in liver transplantation Transpl Int 22 2009 49 60
149. R.J. Firpi, T.T. Tran, P. Flores, and et al. Sirolimus-induced hyperlipidaemia in liver transplant recipients is not dose-dependent Aliment Pharmacol Ther 19 2004 1033 1039
150. B.A. Neuschwander-Tetri, R. Loomba, A.J. Sanyal, and et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial Lancet 385 2015 956 965
151. K.R. Chi The NASH drug dash Nat Rev Drug Discov 14 2015 447 448
152. S. Milic, I. Mikolasevic, I. Krznaric-Zrnic, and et al. Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options Drug Des Devel Ther 9 2015 4835 4845